DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Acceleron Pharma Inc. (XLRN)
« Back to company indexXLRN Chatter Timeline
Stock Ticker for XLRN
Most Active Tweeters for XLRN
| User | Tweets |
|---|---|
| @AmericanBanking | 9 |
| @bulletin_en | 8 |
| @OlympiaReport | 7 |
| @TheMarketsDaily | 4 |
| @WeekHerald | 3 |
Recent Tweets for XLRN
 |
@bulletin_en LogicBio Therapeutics Inc. $XLRN Comparing side by side https://t.co/MBT8GTlSh5 May 23rd 2019, 8:05pm |
|
@bulletin_en Seelos Therapeutics Inc. $XLRN Contrasting side by side https://t.co/J7Jp7VyoVq May 23rd 2019, 5:05pm |
 |
@IlliniJJ $XLRN starting to wake up with a couple of 2H 2019 read outs: https://t.co/CNO3ZgB6Rm May 22nd 2019, 3:05pm |
 |
@ConsumerFeed Zacks Investment Research Lowers Acceleron Pharma $XLRN to Hold https://t.co/6j7W4NYTiM May 21st 2019, 2:05am |
 |
@AmericanBanking $27.14 Million in Sales Expected for Acceleron Pharma Inc $XLRN This Quarter https://t.co/iRwg6x8uZK #stocks May 21st 2019, 1:05am |
 |
@dispatchtribune Acceleron Pharma $XLRN Lowered to “Hold” at Zacks Investment Research https://t.co/sdzQ2Q7KQ3 May 20th 2019, 5:05am |
|
@AmericanBanking Brokerages Expect Acceleron Pharma Inc $XLRN Will Announce Earnings of -$0.23 Per Share https://t.co/xbLEjyZ7y5 #stocks May 20th 2019, 12:05am |
 |
@OlympiaReport Acceleron Pharma $XLRN Cut to “Hold” at Zacks Investment Research https://t.co/cRAWZZxvaF May 18th 2019, 2:05pm |
|
@bulletin_en Contrasting of Arcus Biosciences Inc. $XLRN https://t.co/Tb5vY2BIa6 May 18th 2019, 1:05pm |
 |
@dailypoliticaln Acceleron Pharma $XLRN Downgraded by Zacks Investment Research https://t.co/msuILRo9I1 May 17th 2019, 3:05pm |
 |
@ThisLincolnian Acceleron Pharma $XLRN Price Target Increased to $69.00 by Analysts at HC Wainwright https://t.co/FDnqR88zdy May 17th 2019, 2:05am |
 |
@WeekHerald Acceleron Pharma $XLRN Price Target Increased to $69.00 by Analysts at HC Wainwright https://t.co/ZCuM2jiwOU May 17th 2019, 2:05am |
|
@OlympiaReport Acceleron Pharma $XLRN Price Target Increased to $69.00 by Analysts at HC Wainwright https://t.co/73AEAiVKFO May 17th 2019, 2:05am |
 |
@macondailynews HC Wainwright Raises Acceleron Pharma $XLRN Price Target to $69.00 https://t.co/lfPvXydtBu May 16th 2019, 5:05am |
 |
@bbnsnews Acceleron Pharma $XLRN Rating Reiterated by Cowen https://t.co/BiwBOw2qLo May 16th 2019, 2:05am |
|
@bulletin_en Reviewing DelMar Pharmaceuticals Inc. $XLRN's results https://t.co/vKHdwKu2DV May 15th 2019, 10:05pm |
|
@AmericanBanking Acceleron Pharma $XLRN – Analysts’ Weekly Ratings Updates https://t.co/bYbCcwkp1s #stocks May 15th 2019, 6:05am |
|
@OlympiaReport Acceleron Pharma $XLRN – Analysts’ Weekly Ratings Updates https://t.co/Gks6SnMJqN May 15th 2019, 6:05am |
|
@OlympiaReport Acceleron Pharma $XLRN Rating Reiterated by Cowen https://t.co/uihYK7hRsr May 15th 2019, 4:05am |
 |
@TheMarketsDaily Acceleron Pharma $XLRN PT Raised to $69.00 at HC Wainwright https://t.co/2A1efZQju0 May 15th 2019, 4:05am |
|
@bulletin_en Reviewing AnaptysBio Inc. $XLRN's results https://t.co/JoVwrPBrsk May 15th 2019, 3:05am |
 |
@AcceleronPharma Save the date! $XLRN will be presenting at the @UBS Global Healthcare Conference on 5/20 at 11am EDT. Webcast detai… https://t.co/OY6P7EoM1p May 14th 2019, 7:05am |
 |
@TickerReport Piper Jaffray Companies Reiterates “Overweight” Rating for Acceleron Pharma $XLRN https://t.co/jLSReyyQzB May 14th 2019, 5:05am |
|
@dailypoliticaln Piper Jaffray Companies Reiterates “Overweight” Rating for Acceleron Pharma $XLRN https://t.co/2ejaex5CbZ May 14th 2019, 5:05am |
 |
@ZolmaxNews Piper Jaffray Companies Reiterates “Overweight” Rating for Acceleron Pharma $XLRN https://t.co/BhgUQIpL5v May 14th 2019, 5:05am |
 |
@WKRBNews Acceleron Pharma $XLRN Given Buy Rating at Cowen https://t.co/V5SG2XcWYB #markets May 14th 2019, 5:05am |
|
@OlympiaReport Acceleron Pharma Inc $XLRN to Post FY2022 Earnings of $1.60 Per Share, Piper Jaffray Companies Forecasts https://t.co/LBFVr0CFkl May 14th 2019, 4:05am |
|
@TickerReport Acceleron Pharma $XLRN Upgraded by BidaskClub to Sell https://t.co/UP5V6kBIPt May 14th 2019, 2:05am |
|
@dailypoliticaln Acceleron Pharma $XLRN Upgraded by BidaskClub to Sell https://t.co/HIn8F1Hvxt May 14th 2019, 2:05am |
 |
@WatchlistN Acceleron Pharma $XLRN Upgraded by BidaskClub to Sell https://t.co/vwJ8BEdJMt May 14th 2019, 2:05am |
|
@bulletin_en Bellicum Pharmaceuticals Inc. $XLRN https://t.co/Pb3h8yrmNU May 13th 2019, 7:05pm |
|
@AmericanBanking HC Wainwright Raises Acceleron Pharma $XLRN Price Target to $69.00 https://t.co/HPm1mWdA0t #stocks May 13th 2019, 6:05pm |
|
@ThisLincolnian Acceleron Pharma $XLRN Rating Reiterated by Cowen https://t.co/D5d4dZotOt May 13th 2019, 10:05am |
|
@OlympiaReport Acceleron Pharma’s $XLRN “Overweight” Rating Reiterated at Piper Jaffray Companies https://t.co/utirMveApE May 13th 2019, 8:05am |
|
@AmericanBanking Acceleron Pharma Inc $XLRN Expected to Earn FY2022 Earnings of $1.60 Per Share https://t.co/90oycgUwVD #stocks May 13th 2019, 4:05am |
|
@OlympiaReport Acceleron Pharma $XLRN Upgraded at BidaskClub https://t.co/s4rBzJuiVS May 13th 2019, 3:05am |
|
@WeekHerald Acceleron Pharma $XLRN Upgraded at BidaskClub https://t.co/ecYAnmTDFU May 13th 2019, 3:05am |
|
@ThisLincolnian Acceleron Pharma $XLRN Upgraded to “Sell” at BidaskClub https://t.co/sUAnF55pdd May 13th 2019, 3:05am |
|
@TheMarketsDaily Cowen Reaffirms Buy Rating for Acceleron Pharma $XLRN https://t.co/9jHqhg2Fef May 12th 2019, 2:05pm |
|
@AmericanBanking Acceleron Pharma’s $XLRN Buy Rating Reaffirmed at Cowen https://t.co/uZeaGIkbaK #stocks May 12th 2019, 2:05pm |
|
@bulletin_en Acceleron Pharma $XLRN Shareholder Perceptive Advisors Has Cut Holding by $27.42 Million as Market Value Declined;… https://t.co/lgxIDBunJy May 12th 2019, 11:05am |
 |
@stocknewstimes Acceleron Pharma $XLRN Given “Overweight” Rating at Piper Jaffray Companies https://t.co/xxJrD59Azp May 12th 2019, 10:05am |
 |
@SleekMoneycom Acceleron Pharma $XLRN Given “Overweight” Rating at Piper Jaffray Companies https://t.co/8pL7B8gk9E #investing May 12th 2019, 10:05am |
|
@TheMarketsDaily Acceleron Pharma $XLRN Upgraded to “Sell” by BidaskClub https://t.co/TBG7eBX0Fo May 12th 2019, 2:05am |
 |
@intercooleronli Acceleron Pharma $XLRN Cut to “Buy” at ValuEngine https://t.co/8J8NGskQLI #investingnews May 12th 2019, 12:05am |
 |
@ledgerzette Acceleron Pharma $XLRN Cut to “Buy” at ValuEngine https://t.co/4OIVJeZceO #stocks May 12th 2019, 12:05am |
|
@macondailynews Acceleron Pharma’s $XLRN “Overweight” Rating Reiterated at Piper Jaffray Companies https://t.co/aUmnbKeZoP May 11th 2019, 3:05pm |
|
@WatchlistN Acceleron Pharma $XLRN Posts Earnings Results, Misses Expectations By $0.07 EPS https://t.co/2Lfmrv8Kse May 11th 2019, 10:05am |
|
@AmericanBanking Acceleron Pharma Inc $XLRN Given Consensus Recommendation of “Buy” by Brokerages https://t.co/jEJ2POJ2OD #stocks May 11th 2019, 7:05am |
|
@stocknewstimes Acceleron Pharma $XLRN Upgraded to “Sell” at BidaskClub https://t.co/DzRzr31tkY May 11th 2019, 12:05am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.